会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Production process of polyphenylene ether
    • 聚苯醚的生产工艺
    • US06489439B2
    • 2002-12-03
    • US09883388
    • 2001-06-19
    • Akira MitsuiYuji Takeda
    • Akira MitsuiYuji Takeda
    • C08G6544
    • C08G65/44
    • A process for producing a polyphenylene ether by oxidative polymerization of a phenol compound using a catalyst and an oxygen-containing gas, wherein the catalyst comprises a copper compound, a bromine compound, a diamine compound represented by the following formula (1): (wherein, R1, R2, R3 and R4 each independently represents hydrogen or a C1-6 linear or branched alkyl group with the proviso that all of them do not represent hydrogen simultaneously, and R5 represents a linear or methyl-branched C2-5 alkylene group), a tertiary monoamine compound and a secondary monoamine compound, wherein the process comprises the steps of: controlling an absolute pressure at a gaseous phase of a reaction vessel to a range of from 0.098 MPa to less than 0.392 MPa; and feeding the oxygen-containing gas to the reaction vessel, the oxygen-containing gas having an oxygen partial pressure, in terms of an absolute pressure, of from 0.0147 MPa to 0.0883 MPa.
    • 一种通过使用催化剂和含氧气体的酚化合物的氧化聚合制备聚苯醚的方法,其中催化剂包括铜化合物,溴化合物,由下式(1)表示的二胺化合物:(其中 ,R 1,R 2,R 3和R 4各自独立地表示氢或C 1-6直链或支链烷基,条件是它们全部不同时代表氢,R5表示直链或支链的C 2-5亚烷基) 叔胺化合物和仲单胺化合物,其中该方法包括以下步骤:将反应容器气相的绝对压力控制在0.098MPa至小于0.392MPa的范围内; 并将含氧气体供给到反应容器中,具有0.0147MPa〜0.0883MPa的氧分压为绝对压力的含氧气体。
    • 3. 发明授权
    • Production process of polyphenylene ether
    • US06521735B2
    • 2003-02-18
    • US09883264
    • 2001-06-19
    • Akira MitsuiYuji Takeda
    • Akira MitsuiYuji Takeda
    • C08G6538
    • C08G65/44
    • A process for producing a polyphenylene ether by oxidative polymerization of a phenol compound using a catalyst and an oxygen-containing gas, wherein said catalyst comprises a copper compound, a bromine compound, a diamine compound of formula (1) as recited in the specification, a tertiary monoamine compound and a secondary monoamine compound, and wherein said process comprises the steps of: preparing a catalyst component (P1) in a container which is under a substantially oxygen-free inert atmosphere by mixing the copper compound and the bromine compound to obtain a mixture and then mixing the mixture with the secondary monoamine compound in an amount of at least 2 times the molar amount of the copper atom; separately preparing a catalyst component (P2) by mixing the diamine compound of formula (1) and the tertiary monoamine compound together with a solvent in an oxidative polymerization vessel; adding a predetermined amount of the catalyst component (P1) to the polymerization vessel containing the catalyst component (P2), and mixing the catalyst components (P1) and (P2); and initiating oxidative polymerization.
    • 4. 发明授权
    • Vibratory mechanism and vibratory roller
    • 振动机构和振动辊
    • US07213479B2
    • 2007-05-08
    • US10785130
    • 2004-02-24
    • Akira Mitsui
    • Akira Mitsui
    • F16H33/10
    • E02D3/026E01C19/286Y10T74/18344Y10T74/18544Y10T74/18552
    • A vibratory mechanism includes vibratory shafts, which are stored within a roll and are arranged symmetrically across a rotation axis of the roll, fixed eccentric weights fixed to respective vibratory shafts, rotatable eccentric weights rotatably attached to respective vibratory shafts, a rotation controller controlling a range of movement of the rotatable eccentric weights, and an eccentric moment controller which changes an eccentric moment around the vibratory shaft depending on the rotation direction of the vibratory shafts, whereby the vibration state of the roll is switchable between standard vibration and horizontal vibration.
    • 振动机构包括振动轴,其存储在辊内并且对称地跨过辊的旋转轴线布置,固定到各个振动轴的固定偏心重块,可旋转地附接到各个振动轴的旋转偏心轮,控制范围的旋转控制器 以及偏心力矩控制器,该偏心力矩控制器根据振动轴的旋转方向改变围绕振动轴的偏心力矩,从而可以在标准振动和水平振动之间切换辊的振动状态。
    • 10. 发明申请
    • DRUGS FOR TREATING DIABETES
    • 用于治疗糖尿病的药物
    • US20070071794A1
    • 2007-03-29
    • US11561518
    • 2006-11-20
    • Mihoko TsujiAkira Mitsui
    • Mihoko TsujiAkira Mitsui
    • A61K31/4172A61K31/401A61K31/198A61K47/00
    • A61K45/06A23L33/175A61K31/198A61K31/401A61K31/4172A61K2300/00
    • The present invention provides an agent for recovering insulin secretion function which contains at least one of the amino acids selected from the group consisting of aspartic acid, cystine, serine, asparagine, isoleucine, histidine, hydroxyproline, glutamic acid, valine and salts thereof as an active ingredient; a functional food which contains the agent for recovering insulin secretion function; and a composition for treating diabetes which contains the amino acid(s) and a second diabetic drug as active ingredients. This agent for recovering insulin secretion function can be used as an oral therapeutic agent or functional food that is useful for treating, improving or preventing insulin secretion defects in Type II diabetes, borderline diabetes and other diseases, and side effects caused by administration of drugs.
    • 本发明提供了一种用于回收胰岛素分泌功能的试剂,其含有选自天冬氨酸,胱氨酸,丝氨酸,天冬酰胺,异亮氨酸,组氨酸,羟脯氨酸,谷氨酸,缬氨酸及其盐中的至少一种氨基酸作为 有效成分; 含有胰岛素分泌功能恢复剂的功能性食品; 以及用于治疗含有氨基酸的糖尿病的组合物和作为活性成分的第二糖尿病药。 用于回收胰岛素分泌功能的药剂可以用作口服治疗剂或功能性食品,其可用于治疗,改善或预防II型糖尿病,边缘性糖尿病等疾病中的胰岛素分泌缺陷,以及由药物施用引起的副作用。